Literature DB >> 30270204

Therapy-related acute lymphoblastic leukemia.

Josep-Maria Ribera1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30270204      PMCID： PMC6165810          DOI： 10.3324/haematol.2018.200311

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

Review 1.  Therapy-associated lymphoid proliferations.

Authors:  Adam Bagg
Journal:  Adv Anat Pathol       Date:  2011-05       Impact factor: 3.875

2.  Therapy-related ALL: cytogenetic features and hematopoietic cell transplantation outcome.

Authors:  I Aldoss; A Dagis; J Palmer; S Forman; V Pullarkat
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

3.  Philadelphia chromosome as a recurrent event among therapy-related acute leukemia.

Authors:  Ibrahim Aldoss; Tracey Stiller; Joo Song; Monzr Al Malki; Haris Ali; Amandeep Salhotra; Ahmed Aribi; Samer Khaled; Popsie Gaytan; Joyce Murata-Collins; Joycelynne Palmer; David Snyder; Margaret O'Donnell; Ryotaro Nakamura; Anthony S Stein; Stephen J Forman; Guido Marcucci; Vinod Pullarkat
Journal:  Am J Hematol       Date:  2017-02       Impact factor: 10.047

4.  Precursor B-acute lymphoblastic leukemia occurring in patients with a history of prior malignancies: is it therapy-related?

Authors:  Guilin Tang; Zhuang Zuo; Deborah A Thomas; Pei Lin; Dingsheng Liu; Ying Hu; Hagop M Kantarjian; Carlos Bueso-Ramos; L Jeffrey Medeiros; Sa A Wang
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

5.  Secondary Philadelphia chromosome acquired during therapy of acute leukemia and myelodysplastic syndrome.

Authors:  Habibe Kurt; Lan Zheng; Hagop M Kantarjian; Guilin Tang; Farhad Ravandi-Kashani; Guillermo Garcia-Manero; Zimu Gong; Hesham M Amin; Sergej N Konoplev; Mark J Routbort; Xin Han; Wei Wang; L Jeffery Medeiros; Shimin Hu
Journal:  Mod Pathol       Date:  2018-02-14       Impact factor: 7.842

6.  Acute lymphoblastic leukaemia occurring as second malignancy: report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

Authors:  L Pagano; A Pulsoni; M E Tosti; L Annino; A Mele; A Camera; B Martino; C Guglielmi; R Cerri; E Di Bona; R Invernizzi; C Castagnola; R Bassan; L Mele; G Todeschini; G Leone; F Mandelli
Journal:  Br J Haematol       Date:  1999-09       Impact factor: 6.998

7.  Therapy-related B-lymphoblastic leukemia associated with Philadelphia chromosome and MLL rearrangement: Single institution experience and the review of the literature.

Authors:  Rahul Matnani; Vishwas Parekh; Uma Borate; Jason Brazelton; Vishnu Reddy; Deniz Peker
Journal:  Pathol Int       Date:  2015-08-11       Impact factor: 2.534

8.  Biologic features and treatment outcome of secondary acute lymphoblastic leukemia--a review of 101 cases.

Authors:  R Shivakumar; W Tan; G E Wilding; E S Wang; M Wetzler
Journal:  Ann Oncol       Date:  2008-05-07       Impact factor: 32.976

9.  Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.

Authors:  Abhisek Swaika; Ryan D Frank; Dongyun Yang; Laura E Finn; Liuyan Jiang; Pooja Advani; Asher A Chanan-Khan; Sikander Ailawadhi; James M Foran
Journal:  Cancer Med       Date:  2017-12-28       Impact factor: 4.452

10.  Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.

Authors:  Ibrahim Aldoss; Tracey Stiller; Ni-Chun Tsai; Joo Y Song; Thai Cao; N Achini Bandara; Amandeep Salhotra; Samer Khaled; Ahmed Aribi; Monzr M Al Malki; Matthew Mei; Haris Ali; Ricardo Spielberger; Margaret O'Donnell; David Snyder; Thomas Slavin; Ryotaro Nakamura; Anthony S Stein; Stephen J Forman; Guido Marcucci; Vinod Pullarkat
Journal:  Haematologica       Date:  2018-06-14       Impact factor: 9.941
View more
  6 in total

Review 1.  Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Acute Leukemia.

Authors:  Ram Vasudevan Nampoothiri; Auro Viswabandya
Journal:  Indian J Hematol Blood Transfus       Date:  2020-08-12       Impact factor: 0.915

2.  Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival.

Authors:  M Chantadisai; H R Kulkarni; R P Baum
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-11-27       Impact factor: 9.236

3.  A case of therapy-related acute lymphoblastic leukemia following the treatment of acute myeloid leukemia.

Authors:  Sufana Shikdar; Yuan Ying; Mohamad Khawandanah
Journal:  Leuk Res Rep       Date:  2022-03-01

4.  Lenalidomide induced secondary Acute Lymphoblastic Leukemia in a Multiple Myeloma patient: A case-report.

Authors:  Dr Saqib Raza Khan; Dr Muhammad Tariq; Dr Sidra Malik Fayyaz; Salman Muhammad Soomar; Dr Munira Moosajee
Journal:  Leuk Res Rep       Date:  2022-04-13

5.  Role of radiotherapy and chemotherapy in the risk of leukemia after childhood cancer: An international pooled analysis.

Authors:  Rodrigue S Allodji; Margaret A Tucker; Michael M Hawkins; Marie-Cécile Le Deley; Cristina Veres; Rita Weathers; Rebecca Howell; Dave Winter; Nadia Haddy; Carole Rubino; Ibrahima Diallo; Mark P Little; Lindsay M Morton; Florent de Vathaire
Journal:  Int J Cancer       Date:  2020-11-09       Impact factor: 7.316

6.  Acute Lymphoblastic Leukemia in a Patient Treated with Letrozole and Palbociclib.

Authors:  Jin Hyun Park; Hyunkyung Park; Ki Hwan Kim; Jin-Soo Kim; In Sil Choi; Eun Youn Roh; Ji Eun Kim; Mee Soo Chang
Journal:  J Breast Cancer       Date:  2019-11-13       Impact factor: 3.588
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.